In vitro activity of ponazuril against Theileria equi

Veterinary Parasitology

Volumn 185, Issue 2-4, 2012, Pages 282-285

  Wise, L Nicki ^a,b   Ueti, Massaro W ^b   Kappmeyer, Lowell S ^b   Hines, Melissa T ^c   White, Stephen N ^a,b   Davis, Wendell ^d   Knowles, Donald P ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d BAYER CORPORATION   (United States)

Author keywords

Piroplasmosis; Ponazuril; Therapy

Indexed keywords

PONAZURIL;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CONCENTRATION; EQUINE PIROPLASMOSIS; ERYTHROCYTE; IN VITRO STUDY; NONHUMAN; PARASITE PHENOMENA AND FUNCTIONS; PARASITE REPLICATION INHIBITION; THEILERIA; THEILERIA EQUI;

ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HORSES; THEILERIA; TRIAZINES;

EQUIDAE; THEILERIA EQUI; TOXOPLASMA GONDII;

EID: 84858282242     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.10.036     Document Type: Article

References (23)

1. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., Igarashi I. Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. Am. J. Trop. Med. Hyg. 2003, 68:334-340.
2. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., Igarashi I. Clotrimazole, ketoconazole, and clodinafop-propargyl as potent growth inhibitors of equine Babesia parasites during in vitro culture. J. Parasitol. 2003, 89:604-606.
3. Bork S., Yokoyama N., Ikehara Y., Kumar S., Sugimoto C., Igarashi I. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob. Agents Chemother. 2004, 48:236-241.
4. Dirikolu L., Karpiesiuk W., Lehner A.F., Hughes C., Granstrom D.E., Tobin T. Synthesis and detection of toltrazuril sulfone and its pharmacokinetics in horses following administration in dimethylsulfoxide. J. Vet. Pharmacol. Ther. 2009, 32:368-378.
5. Frerichs W.M., Allen P.C., Holbrook A.A. Equine piroplasmosis (Babesia equi): therapeutic trials of imidocarb dihydrochloride in horses and donkeys. Vet. Rec. 1973, 93:73-75.
6. Furr M., Kennedy T. Cerebrospinal fluid and serum concentrations of ponazuril in horses. Vet. Ther. 2001, 2:232-237.
7. Furr, M., Kennedy, T., 2001b. Pharmacokinetics of ponazuril in horses (Study 150-717 Bayer Corporation).
8. Furr M., Kennedy T., MacKay R., Reed S., Andrews F., Bernard B., Bain F., Byars D. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis. Vet. Ther. 2001, 2:215-222.
9. Holman P.J., Chieves L., Frerichs W.M., Olson D., Wagner G.G. Babesia equi erythrocytic stage continuously cultured in an enriched medium. J. Parasitol. 1994, 80:232-236.
10. Kennedy T., Campbell J., Selzer V. Safety of ponazuril 15% oral paste in horses. Vet. Ther. 2001, 2:223-231.
11. Knowles D.P., Kappmeyer L.S., Perryman L.E. Genetic and biochemical analysis of erythrocyte-stage surface antigens belonging to a family of highly conserved proteins of Babesia equi and Theileria species. Mol. Biochem. Parasitol. 1997, 90:69-79.
12. Kritzner S., Sager H., Blum J., Krebber R., Greif G., Gottstein B. An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Ann. Clin. Microbiol. Antimicrob. 2002, 1:4.
13. Kumar S., Gupta A.K., Pal Y., Dwivedi S.K. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. J. Vet. Med. Sci. 2003, 65:1171-1177.
14. Kuttler K.L., Zaugg J.L., Gipson C.A. Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids. Am. J. Vet. Res. 1987, 48:1613-1616.
15. Levy M.G., Ristic M. Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture. Science 1980, 207:1218-1220.
16. Lindsay D.S., Dubey J.P., Kennedy T.J. Determination of the activity of ponazuril against Sarcocystis neurona in cell cultures. Vet. Parasitol. 2000, 92:165-169.
17. Melhorn H., Schein E. Redescription of Babesia equi Laveran, 1901 as Theileria equi. Parasitol. Res. 1998, 84:467-475.
18. Mitchell S.M., Zajac A.M., Davis W.L., Lindsay D.S. Mode of action of ponazuril against Toxoplasma gondii tachyzoites in cell culture. J. Eukaryot. Microbiol. 2003, 50(Suppl.):689-690.
19. Mitchell S.M., Zajac A.M., Davis W.L., Lindsay D.S. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice. J. Parasitol. 2004, 90:639-642.
20. Nagai A., Yokoyama N., Matsuo T., Bork S., Hirata H., Xuan X., Zhu Y., Claveria F.G., Fujisaki K., Igarashi I. Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures. Antimicrob. Agents Chemother. 2003, 47:800-803.
21. Rothschild C.M., Knowles D.P. Equine piroplasmosis. Equine Infectious Diseases 2006, 465-473. Saunders, St. Louis, MO. D.C. Sellon, M.T. Long (Eds.).
22. Schwint O.N., Ueti M.W., Palmer G.H., Kappmeyer L.S., Hines M.T., Cordes R.T., Knowles D.P., Scoles G.A. Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential. Antimicrob. Agents Chemother. 2009, 53:4327-4332.
23. Short, M., Clark, C., Harvey, J., Wenzlow, N., Hawkins, I., Allred, D., Knowles, D., Corn, J., Grause, J., Hennager, S., Kitchen, D., Traub-Dargatz, J. Review of the equine piroplasmosis outbreak in Florida in 2008, J. Am. Vet. Med. Assoc., in press.